Drug intelligence / Profile preview

Glucocil

Development stage
Unknown
Lead developer
Neuliven Health
Administration
Oral
01

Overview

Glucocil is a **dietary supplement** formulated to promote healthy blood sugar levels and support metabolic health. It is a proprietary blend of 14 ingredients, including mulberry leaf extract, berberine, alpha lipoic acid, chromium picolinate, cinnamon bark, gymnema sylvestre, banaba, veld grape extract, vitamins B1, B6, B12, D3, fish oil, and turmeric. The mechanisms by which Glucocil acts are: reducing sugar absorption in the intestines (primarily via mulberry leaf extract), decreasing hepatic glucose production (notably through berberine and alpha lipoic acid), and enhancing insulin sensitivity and glucose uptake (notably through chromium, berberine, alpha lipoic acid, and gymnema). Glucocil also supports cardiovascular health, healthy weight management, and overall metabolic function. It is not an FDA-approved pharmaceutical drug, but rather is regulated as a dietary supplement in the United States[2][4][5][6][7].

Brand names
Glucocil
Other names
Glucocil
02

Targets

SLC5A1 (Sodium Glucose Cotransporter 1)

Beyond the preview

Go deeper on Glucocil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucocil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call